Collegium Pharmaceutical's total assets for Q2 2025 were $1.59B, a decrease of -2.38% from the previous quarter. COLL total liabilities were $1.36B for the fiscal quarter, a -2.61% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.